Results 181 to 190 of about 3,424 (202)

Arylesterase

2020
openaire   +1 more source

Optimization of PON1 arylesterase activity measurement

2016
Paraoxonase (PON1) prevents the oxidation of low density lipoproteins (LDL) and is associated with the risk of developing atherosclerosis, cardiovascular disease and myocardial infarction. The reduced catalytic activity of PON1 in humans has been demonstrated in many pathological conditions such as diabetes, chronic kidney or liver disease ...
Bosak, Anita, Kovarik, Zrinka
openaire  

[Arylesterase, paraoxonase].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Yukio, Ikeda, Tadashi, Suehiro
openaire   +1 more source

Characterization of a novel oligomeric SGNH-arylesterase from Sinorhizobium meliloti 1021

International Journal of Biological Macromolecules, 2010
, T Doohun Kim, Seungbum Kim
exaly  

Arylesterases

1974
openaire   +1 more source

Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia

Atherosclerosis, 2007
Mehmet Aslan, Ozcan Bektaş, Hakim Çelik   +2 more
exaly  

Arylesterase (ESA, paraoxonase)

2008
openaire   +1 more source

Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment

Clinical Biochemistry, 2009
Suleyman Aydin, Ibrahim Şahin, Ömer Deniz   +2 more
exaly  

Paraoxonase and arylesterase activities in adults with vitamin B12 deficiency

Redox Report, 2016
Ozcan Bektaş, Afra Alkan, Murat Alisik   +2 more
exaly  

[Arylesterase (ArE)].

Nihon rinsho. Japanese journal of clinical medicine, 1996
openaire   +2 more sources